Previous close | 27.20 |
Open | 26.78 |
Bid | 26.50 x 100 |
Ask | 26.59 x 100 |
Day's range | 26.01 - 27.22 |
52-week range | 18.45 - 36.66 |
Volume | |
Avg. volume | 733,260 |
Market cap | 1.115B |
Beta (5Y monthly) | 1.82 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.64 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 33.57 |
SEATTLE, June 12, 2024--Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, and Boehringer Ingelheim, one of the largest innovators in animal disease prevention and treatment globally, today announced a strategic collaboration to provide pets and their families increased access to high-quality healthcare and enhanced disease treatment and protection.
Focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position continue to drive Trupanion (TRUP).
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders should be happy to see the share price up 26% in the last month. But that...